Clinical review: Glucose control in severely burned patients - current best practice

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Jeschke, Marc G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

BLOOD GLUCOSE MONITORING; BURN; BURN PATIENT; CRITICALLY ILL PATIENT; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INJURY SEVERITY; INSULIN RESISTANCE; INTENSIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; BLOOD; BURNS; GLUCOSE BLOOD LEVEL; INTENSIVE CARE UNIT; METABOLISM; SEVERITY OF ILLNESS INDEX; STANDARDS;

BLOOD GLUCOSE; BURNS; HUMANS; INSULIN; INTENSIVE CARE UNITS; SEVERITY OF ILLNESS INDEX;

EID: 84880707961     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12678     Document Type: Review

References (82)

1. Bringham PA, McLoughlin E. Burn incidence and medical care use in the United States: estimates, trends and data sources. J Burn Care Rehabil 1996, 17:95-107. 10.1097/00004630-199603000-00003, 8675512.
2. World Health Organization A Graphical Overview of the Global Burden of Injuries. The Injury Chart Book 2002, 29. Geneva: WHO, World Health Organization.
3. Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet 2004, 363:1895-1902. 10.1016/S0140-6736(04)16360-5, 15183630.
4. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, Branski LK, Gauglitz GG, Mlcak RP, Herndon DN. Pathophysiologic response to severe burn injury. Ann Surg 2008, 248:387-401.
5. Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism 1979, 28:1031-1039. 10.1016/0026-0495(79)90007-6, 491960.
6. Wolfe RR, Herndon DN, Peters EJ, Jahoor F, Desai MH, Holland OB. Regulation of lipolysis in severely burned children. Ann Surg 1987, 206:214-221. 10.1097/00000658-198708000-00016, 1493114, 3606248.
7. Wolfe RR, Jahoor F, Hartl WH. Protein and amino acid metabolism after injury. Diabetes Metab Rev 1989, 5:149-164. 10.1002/dmr.5610050205, 2647433.
8. Wolfe RR, Miller HI, Spitzer JJ. Glucose and lactate kinetics in burn shock. Am J Physiol 1977, 232:E415-E418.
9. Wilmore DW. Hormonal responses and their effect on metabolism. Surg Clin North Am 1976, 56:999-1018.
10. Wilmore DW, Aulick LH. Metabolic changes in burned patients. Surg Clin North Am 1978, 58:1173-1187.
11. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001, 51:540-544. 10.1097/00005373-200109000-00021, 11535907.
12. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 2002, 30:2438-2442. 10.1097/00003246-200211000-00006, 12441751.
13. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery 2008, 144:629-635. 10.1016/j.surg.2008.07.001, 3571713, 18847648.
14. Jeschke MG, Kulp GA, Kraft R, Finnerty CC, Mlcak R, Lee JO, Herndon DN. Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med 2010, 182:351-359. 10.1164/rccm.201002-0190OC, 2921599, 20395554.
15. Gore DC, Ferrando A, Barnett J, Wolf SE, Desai M, Herndon DN, Goodwin C, Wolfe RR. Influence of glucose kinetics on plasma lactate concentration and energy expenditure in severely burned patients. J Trauma 2000, 49:673-678. 10.1097/00005373-200010000-00015, 11038085.
16. Van den Berghe G. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 2000, 342:135. author reply 135-136.
17. Van den Berghe G. Insulin therapy for the critically ill patient. Clin Cornerstone 2003, 5:56-63. 10.1016/S1098-3597(03)90018-4, 12800480.
18. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461. 10.1056/NEJMoa052521, 16452557.
19. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
20. Van den Berghe GH. Role of intravenous insulin therapy in critically ill patients. Endocr Pract 2004, 10(Suppl 2):17-20.
21. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006, 55:1096-1105. 10.2337/diabetes.55.04.06.db05-1434, 16567534.
22. Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, Vanhoutte T, Van Damme A, Schetz M, Wouters PJ, Van den Berghe G. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006, 27:2716-2724. 10.1093/eurheartj/ehi855, 16608860.
23. Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D, Lemiere J, Lagae L, Gewillig M, Eyskens B, Vanhorebeek I, Wouters PJ, Van den Berghe G. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA 2012, 308:1641-1650. 10.1001/jama.2012.12424, 23101118.
24. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003, 290:2041-2047. 10.1001/jama.290.15.2041, 14559958.
25. Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med 2007, 35:S503-S507. 10.1097/01.CCM.0000278046.24345.C7, 17713400.
26. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139. 10.1056/NEJMoa070716, 18184958.
27. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
28. Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chiolero R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35:1738-1748. 10.1007/s00134-009-1585-2, 19636533.
29. Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, Alexander JL, Scoppettuolo LA, Pigula FA, Charpie JR, Ohye RG, Gaies MG. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012, 367:1208-1219. 10.1056/NEJMoa1206044, 3501680, 22957521.
30. Hermayer KL, Egidi MF, Finch NJ, Baliga P, Lin A, Kettinger L, Biggins S, Carter RE. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab 2012, 97:4399-4406. 10.1210/jc.2012-1979, 23074234.
31. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010, 85:217-224. 10.4065/mcp.2009.0394, 2843109, 20176928.
32. Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012, 367:1108-1118.
33. Andel D, Kamolz LP. Blood glucose control in critically ill patients. Minerva Anestesiol 2012, 78:975-976.
34. Schultz MJ, Harmsen RE, Korevaar JC, Abu-Hanna A, Van Braam Houckgeest F, Van Der Sluijs JP, Spronk PE. Adoption and implementation of the original strict glycemic control guideline is feasible and safe in adult critically ill patients. Minerva Anestesiol 2012, 78:982-995.
35. Jeschke MG, Klein D, Thasler WE, Bolder U, Schlitt HJ, Jauch KW, Weiss TS. Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge. Mol Med 2008, 14:11-19. 10.1007/s00894-007-0240-5, 2082131, 18037968.
36. Pham TN, Warren AJ, Phan HH, Molitor F, Greenhalgh DG, Palmieri TL. Impact of tight glycemic control in severely burned children. J Trauma 2005, 59:1148-1154.
37. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008, 454:455-462. 10.1038/nature07203, 2727659, 18650916.
38. Jeschke MG, Finnerty CC, Herndon DN, Song J, Boehning D, Tompkins RG, Baker HV, Gauglitz GG. Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response. Ann Surg 2012, 255:370-378. 10.1097/SLA.0b013e31823e76e7, 3395076, 22241293.
39. Allison SP, Hinton P, Chamberlain MJ. Intravenous glucose-tolerance, insulin, and free-fatty-acid levels in burned patients. Lancet 1968, 2:1113-1116.
40. Hinton P, Allison SP. Insulin and glucose to reduce catabolic response to burns. Lancet 1971, 1:1247.
41. Wilmore DW, Long JM, Mason AD, Skreen RW, Pruitt BA. Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg 1974, 180:653-669. 10.1097/00000658-197410000-00031, 1344163, 4412350.
42. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999, 229:11-18. 10.1097/00000658-199901000-00002, 1191603, 9923795.
43. Pierre EJ, Barrow RE, Hawkins HK, Nguyen TT, Sakurai Y, Desai M, Wolfe RR, Herndon DN. Effects of insulin on wound healing. J Trauma 1998, 44:342-345. 10.1097/00005373-199802000-00019, 9498508.
44. Thomas SJ, Morimoto K, Herndon DN, Ferrando AA, Wolfe RR, Klein D, Wolf SE. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002, 132:341-347. 10.1067/msy.2002.126871, 12219032.
45. Zhang XJ, Chinkes DL, Wolf SE, Wolfe RR. Insulin but not growth hormone stimulates protein anabolism in skin would and muscle. Am J Physiol 1999, 276:E712-E720.
46. Gauglitz GG, Toliver-Kinsky TE, Williams FN, Song J, Cui W, Herndon DN, Jeschke MG. Insulin increases resistance to burn wound infection-associated sepsis. Crit Care Med 2010, 38:202-208. 10.1097/CCM.0b013e3181b43236, 19770742.
47. Cochran A, Davis L, Morris SE, Saffle JR. Safety and efficacy of an intensive insulin protocol in a burn-trauma intensive care unit. J Burn Care Res 2008, 29:187-191.
48. Mann EA, Pidcoke HF, Salinas J, Holcomb JB, Wolf SE, Wade CE. The impact of intensive insulin protocols and restrictive blood transfusion strategies on glucose measurement in American Burn Association (ABA) verified burn centers. J Burn Care Res 2008, 29:718-723. 10.1097/BCR.0b013e3181848c74, 18825791.
49. Gibson BR, Galiatsatos P, Rabiee A, Eaton L, Abu-Hamdah R, Christmas C, Milner SM, Andersen DK, Elahi D. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit. Surgery 2009, 146:922-930. 10.1016/j.surg.2009.04.035, 19733884.
50. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients postburn. J Clin Endocrinol Metab 2009, 94:1656-1664. 10.1210/jc.2008-1947, 2684478, 19240154.
51. Pierre E, Barrow RE, Sakurai Y, Wolfe RR, Herndon DN. Structural effects of insulin on wound healing. Plastic Surg 1996, 36:743-745.
52. Tuvdendorj D, Zhang XJ, Chinkes DL, Aarsland A, Kulp GA, Jeschke MG, Herndon DN. Intensive insulin treatment increases donor site wound protein synthesis in burn patients. Surgery 2011, 149:512-518. 10.1016/j.surg.2010.10.021, 21236451.
53. Zhang XJ, Chinkes DL, Irtun O, Wolfe RR. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. Am J Physiol Endocrinol Metab 2002, 282:E1308-E1315.
54. Zhang XJ, Chinkes DL, Wu Z, Martini WZ, Wolfe RR. Fractional synthesis rates of DNA and protein in rabbit skin are not correlated. J Nutr 2004, 134:2401-2406.
55. Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004, 145:4084-4093. 10.1210/en.2004-0592, 15192048.
56. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004, 239:553-560. 10.1097/01.sla.0000118569.10289.ad, 1356261, 15024317.
57. Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, Croner RS. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 2005, 42:870-879. 10.1016/j.jhep.2004.12.036, 15885358.
58. Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 2004, 240:340-349. 10.1097/01.sla.0000133353.57674.cd, 1356412, 15273560.
59. Aarsland A, Chinkes D, Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 1996, 98:2008-2017. 10.1172/JCI119005, 507644, 8903319.
60. Jeschke MG, Kraft R, Song J, Gauglitz GG, Cox RA, Brooks NC, Finnerty CC, Kulp GA, Herndon DN, Boehning D. Insulin protects against hepatic damage postburn. Mol Med 2011, 17:516-522. 3105152, 21267509.
61. Gauglitz GG, Halder S, Boehning DF, Kulp GA, Herndon DN, Barral JM, Jeschke MG. Post-burn hepatic insulin resistance is associated with endoplasmic reticulum (ER) stress. Shock 2010, 33:299-305. 10.1097/SHK.0b013e3181b2f439, 22011639.
62. Cree MG, Aarsland A, Herndon DN, Wolfe RR. Role of fat metabolism in burn trauma-induced skeletal muscle insulin resistance. Crit Care Med 2007, 35:S476-S483. 10.1097/01.CCM.0000278066.05354.53, 17713396.
63. Cree MG, Fram RY, Herndon DN, Qian T, Angel C, Green JM, Mlcak R, Aarsland A, Wolfe RR. Human mitochondrial oxidative capacity is acutely impaired after burn trauma. Am J Surg 2008, 196:234-239. 10.1016/j.amjsurg.2007.09.048, 3480314, 18639661.
64. Cree MG, Zwetsloot JJ, Herndon DN, Newcomer BR, Fram RY, Angel C, Green JM, Dohm GL, Sun D, Aarsland A, Wolfe RR. Insulin sensitivity is related to fat oxidation and protein kinase C activity in children with acute burn injury. J Burn Care Res 2008, 29:585-594. 10.1097/BCR.0b013e31817db88f, 18535477.
65. Jeschke MG, Boehning D. Endoplasmic reticulum stress and insulin resistance post-trauma: similarities to type 2 diabetes. J Cell Mol Med 2012, 16:437-444. 10.1111/j.1582-4934.2011.01405.x, 3217064, 21812914.
66. Jeschke MG, Kraft R, Emdad F, Kulp GA, Williams FN, Herndon DN. Glucose control in severely thermally injured pediatric patients: what glucose range should be the target?. Ann Surg 2010, 252:521-528.
67. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
68. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637. 10.1097/CCM.0b013e31827e83af, 23353941.
69. Langouche L, Vanhorebeek I, Van den Berghe G. Therapy insight: the effect of tight glycemic control in acute illness. Nat Clin Pract Endocrinol Metab 2007, 3:270-278. 10.1038/ncpendmet0426, 17315035.
70. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003, 31:359-366. 10.1097/01.CCM.0000045568.12881.10, 12576937.
71. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009, 373:547-556. 10.1016/S0140-6736(09)60044-1, 19176240.
72. Pidcoke HF, Wanek SM, Rohleder LS, Holcomb JB, Wolf SE, Wade CE. Glucose variability is associated with high mortality after severe burn. J Trauma 2009, 67:990-995. 10.1097/TA.0b013e3181baef4b, 19901659.
73. Pisarchik AN, Pochepen ON, Pisarchyk LA. Increasing blood glucose variability is a precursor of sepsis and mortality in burned patients. PLoS One 2012, 7:e46582. 10.1371/journal.pone.0046582, 3467236, 23056354.
74. Mann EA, Salinas J, Pidcoke HF, Wolf SE, Holcomb JB, Wade CE. Error rates resulting from anemia can be corrected in multiple commonly used point-of-care glucometers. J Trauma 2008, 64:15-21. 10.1097/TA.0b013e318160b9e4, 18188093.
75. Pidcoke HF, Wade CE, Mann EA, Salinas J, Cohee BM, Holcomb JB, Wolf SE. Anemia causes hypoglycemia in intensive care unit patients due to error in single-channel glucometers: methods of reducing patient risk. Crit Care Med 2010, 38:471-476. 10.1097/CCM.0b013e3181bc826f, 19789438.
76. Damiano ER, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care 2013, 36:251-259. 10.2337/dc12-0070, 23275350.
77. Mecott GA, Herndon DN, Kulp GA, Brooks NC, Al-Mousawi AM, Kraft R, Rivero HG, Williams FN, Branski LK, Jeschke MG. The use of exenatide in severely burned pediatric patients. Crit Care 2010, 14:R153. 10.1186/cc9222, 2945137, 20701787.
78. Gore DC, Herndon DN, Wolfe RR. Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury. J Trauma 2005, 59:316-323. 10.1097/01.ta.0000180387.34057.5a, 16294070.
79. Gore DC, Wolf SE, Herndon DN, Wolfe RR. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma 2003, 54:555-561. 10.1097/01.TA.0000026990.32856.58, 12634538.
80. Gore DC, Wolf SE, Sanford A, Herndon DN, Wolfe RR. Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury. Ann Surg 2005, 241:334-342. 10.1097/01.sla.0000152013.23032.d1, 1356920, 15650645.
81. Cree MG, Newcomer BR, Herndon DN, Qian T, Sun D, Morio B, Zwetsloot JJ, Dohm GL, Fram RY, Mlcak RP, Aarsland A, Wolfe RR. PPAR-alpha agonism improves whole body and muscle mitochondrial fat oxidation, but does not alter intracellular fat concentrations in burn trauma children in a randomized controlled trial. Nutr Metab (Lond) 2007, 4:9. 10.1186/1743-7075-4-9, 1868739, 17451602.
82. Elijah IE, Borsheim E, Maybauer DM, Finnerty CC, Herndon DN, Maybauer MO. Role of the PPAR-alpha agonist fenofibrate in severe pediatric burn. Burns 2012, 38:481-486. 10.1016/j.burns.2011.12.004, 3669757, 22226866.